Tag: boston scientific

October 19, 2017

BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022

BioSig Technologies, Inc. (BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need within...
April 25, 2017

BioSig Technologies Provides Shareholder Update

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address...
April 7, 2017

BioSig Technologies Completes Private Placement

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address...
March 24, 2017

Neovasc Posts Financial Results For 2016

Neovasc (TSX:NVCN) announced their financial results for 2016 and their fourth quarter.
March 17, 2017

BioSig Technologies Announces Strategic Partnership with Mayo Clinic

BioSig Technologies (OTCQB:BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet...
January 9, 2017

Medical Device Trends 2017: Doubts on Policy and the Rise of Cyber Threats

A market currently estimated to be worth $389 billion worldwide medical devices enjoyed a positive developing year in 2017. However,...
November 22, 2016

Boston Scientific Acquires EndoChoice

Boston Scientific has completed its acquisition of EndoChoice Holdings, the company announced today.